May 14, 2019  NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds (River Cities). “This funding will be instrumental in fueling rapid growth for Catalyst through increased inventory, expanded distribution and new product …